Drug discovery quarterly review: Second quarter 2023
Drug Discovery World
SEPTEMBER 14, 2023
As the second quarter of 2023 draws to a close, DDW’s Megan Thomas reviews key updates and results from three top pharmaceutical companies. joined Pfizer’s Executive Leadership Team as Chief Oncology Research and Development Officer and Executive Vice President reporting to Chairman and Chief Executive Officer, Albert Bourla.
Let's personalize your content